Malik Fady Ibraham's Form 4 filing
Cytokinetics Inc (CYTK) · filed Feb 6, 2024
- Accession no.
- 0001127602-24-003582
- Filed
- Feb 6, 2024
- Trade date
- Feb 6, 2024
- Filing delay
- Same day
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $2.59M. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Malik Fady IbrahamCIK 0001551778 | Officer (EVP Research & Development) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 6, 2024 | Common Stock | MOption exerciseAcquired | +28,605 | $6.67 | +$190,795.35 | 175,578 | Direct | |
| Feb 6, 2024 | Common Stock | SSaleDisposed | −28,605 | $79.30 | −$2,268,376.5 | 146,973 | Direct | |
| Feb 6, 2024 | Common Stock | SSaleDisposed | −4,000 | $79.28 | −$317,120 | 142,973 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 6, 2024 | Common Stock | MOption exerciseDisposed | −28,605 | $0.00 | $0 | 57,209 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.